NCT00047281View on ClinicalTrials.gov

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

February 28, 2006

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

celecoxib

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

thalidomide

Trial Locations (3)

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Brigham and Women's Hospital, Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

Sponsors

Collaborators (2)

Schering-Plough
Celgene
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Schering-Plough

INDUSTRY

collaborator

Celgene

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER